You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,000,499


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,000,499 protect, and when does it expire?

Patent 11,000,499 protects VASCEPA and is included in one NDA.

This patent has forty-seven patent family members in twenty-one countries.

Summary for Patent: 11,000,499
Title:Methods of reducing the risk of cardiovascular events in a subject
Abstract: In various embodiments, the present disclosure provides methods reducing the risk of cardiovascular events in a subject on statin therapy by administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.
Inventor(s): Soni; Paresh (Mystic, CT)
Assignee: Amarin Pharmaceuticals Ireland Limited (Dublin, IE)
Application Number:16/927,224
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis Using US Patent 11,000,499 as an Example

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the key aspects of patent scope and claims, using US Patent 11,000,499 as a case study to illustrate these concepts.

What is a Patent?

A patent is a government-granted right that allows the patent holder to exclude others from making, using, or selling an invention for a specified period, typically 20 years from the filing date of the patent application[4].

The Importance of Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention and what is protected by the patent. Claims must be clear, concise, and supported by the patent specification[4].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Determining Patent Scope

The scope of a patent is determined by the claims, which must be interpreted in light of the specification and the prosecution history of the patent.

Metrics for Measuring Patent Scope

Research has identified simple metrics to measure patent scope, such as:

  • Independent Claim Length: Longer claims often indicate broader or more complex inventions.
  • Independent Claim Count: More claims can suggest a broader scope of protection[3].

The Role of the Specification

The specification describes the invention in detail, including drawings and flowcharts. It must provide enough information for a person with ordinary skill in the field to make and use the invention without undue experimentation[4].

Example from US Patent 11,000,499

While the specific details of US Patent 11,000,499 are not provided here, a typical patent specification would include:

  • Detailed Description: A thorough explanation of the invention, its components, and how it works.
  • Drawings and Flowcharts: Visual aids to help understand the invention.
  • Examples: Illustrative examples of how the invention can be used or implemented.

Claim Construction and Indefiniteness

Claim construction is the process of interpreting the meaning of the claims, which is a question of law reviewed de novo on appeal. Claims must be definite to be valid; indefiniteness can render a claim invalid[2].

Case Study: Nature Simulation Systems Inc. v. Autodesk, Inc.

In this case, the district court erred by applying an incorrect standard for claim indefiniteness. The court did not construe the claims using the intrinsic record (the patent document itself, including the claims, specification, and prosecution history) and extrinsic evidence. The Federal Circuit reversed the decision, emphasizing the importance of proper claim construction[2].

Continuation Applications and Their Impact on Patent Scope

Continuation applications can significantly affect the scope and number of patents derived from a progenitor application.

  • Continuation-in-Part (CIP): Allows new subject matter to be added to an existing application.
  • Divisional Applications: Separate distinct inventions claimed in the same application.
  • Serialized Continuations: Can result in multiple patents from a single progenitor application, complicating the calculation of allowance rates[1].

Inventorship and Its Impact on Patent Validity

Inventorship is a critical aspect of patent law. Only those who conceive the subject matter of at least one claim are considered inventors. Errors in inventorship, especially those made with deceptive intent, can render a patent unenforceable[4].

Key Points in Determining Inventorship

  • Conception: The formation of a definite and permanent idea of the complete and operative invention.
  • Reduction to Practice: While important, this step alone does not qualify someone as an inventor unless they also conceived the invention.
  • Collaborative Efforts: Multiple individuals can be inventors if they collaborate to produce the invention through aggregate efforts[4].

Patent Allowance Rates and Their Significance

Understanding patent allowance rates can provide insights into the likelihood of a patent being granted.

  • First-Action Allowance Rate: The proportion of applications allowed without further examination.
  • Progenitor Allowance Rate: The proportion of applications allowed without any continuation procedure.
  • Family Allowance Rate: The proportion of applications that produce at least one patent, including outcomes of continuation applications[1].

The Impact of Technology Fields on Patent Scope

Different technology fields have varying complexities and requirements, affecting the scope and validity of patents.

  • Broad Technology Fields: Such as Chemical, Drugs and Medical, Electrical and Electronics, and Computers and Communications, each with unique challenges and standards[1].

Practical Considerations for Patent Applicants

  • Clear and Concise Claims: Ensure claims are well-defined to avoid indefiniteness issues.
  • Thorough Specification: Provide detailed descriptions and drawings to support the claims.
  • Proper Inventorship: Accurately identify and list all inventors to avoid validity issues.
  • Strategic Use of Continuation Applications: Utilize continuation procedures to maximize the scope of protection while avoiding unnecessary complexity[1][2][4].

Key Takeaways

  • Patent Claims Define the Scope: Claims are the core of a patent and must be clear and supported by the specification.
  • Specification and Drawings: These provide the necessary detail for a person with ordinary skill to make and use the invention.
  • Claim Construction is Critical: Proper interpretation of claims is essential for validity and enforcement.
  • Inventorship Must Be Accurate: Errors in inventorship can lead to unenforceable patents.
  • Continuation Applications Can Expand Scope: But must be used strategically to avoid complications.

FAQs

What is the significance of patent claims in defining the scope of a patent?

Patent claims are crucial as they define what is protected by the patent and must be clear, concise, and supported by the specification.

How do continuation applications affect the scope of a patent?

Continuation applications can expand the scope by allowing new subject matter, separating distinct inventions, or resulting in multiple patents from a single progenitor application.

What is the importance of accurate inventorship in patent applications?

Accurate inventorship is vital as errors, especially those made with deceptive intent, can render a patent unenforceable.

How are patent allowance rates calculated, and what do they indicate?

Patent allowance rates are calculated based on first-action allowances, progenitor allowances, and family allowances, indicating the likelihood of a patent being granted.

What metrics can be used to measure the scope of a patent?

Metrics such as independent claim length and independent claim count can be used to measure the scope and complexity of a patent.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent? The Yale Journal of Law & Technology.
  2. United States Court of Appeals for the Federal Circuit. (2022, October 17). Nature Simulation Systems Inc. v. Autodesk, Inc. Case No. 20-2257.
  3. SSRN. (2016, September 29). Patent Claims and Patent Scope.
  4. Oregon State University. (n.d.). Determining Inventorship for US Patent Applications.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,000,499

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-001 Jul 26, 2012 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe USE OF VASCEPA AS AN ADJUNCT TO STATIN THERAPY TO REDUCE THE RISK OF A SECOND AND FURTHER CARDIOVASCULAR EVENT IN AN ADULT PATIENT WITH ESTABLISHED CARDIOVASCULAR DISEASE ⤷  Subscribe
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-002 Feb 16, 2017 AB RX Yes No ⤷  Subscribe ⤷  Subscribe USE OF VASCEPA AS AN ADJUNCT TO STATIN THERAPY TO REDUCE THE RISK OF A SECOND AND FURTHER CARDIOVASCULAR EVENT IN AN ADULT PATIENT WITH ESTABLISHED CARDIOVASCULAR DISEASE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.